학술논문
A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant
Document Type
Article
Author
Source
In Vaccine 27 May 2016 34(25):2847-2854
Subject
Language
ISSN
0264-410X